Immix Biopharma Announces Late-Breaking Nxc-201 Clinical Data Abstract Accepted for Oral Presentation at the 27TH Annual Meeting of the American Society of Gene and Cell Therapy (Asgct)
Immix Biopharma宣佈最新發布的Nxc-201臨床數據摘要獲准在美國基因與細胞療法學會（Asgct）第27屆年會上進行口頭陳述